bioMerieux Clarion Patient Health Data Collection Solution

Main articles:

• Defining Business Intelligence
• SaaS - History. Philosophy. Development Drivers
• Data management

2021: Clarion View

On August 16, 2021, SAS, a representative in the field of analytics and artificial intelligence (AI), said that together with bioMerieux Inc., a company working in the field of solutions for diagnosing infectious diseases in vitro, they entered into a partnership agreement to jointly solve the problems of using antibacterial drugs.

Issues of expediency and side effects from antibiotics are especially acute, as pandemic COVID-19 cases of their uncontrolled appointment and reception have become more frequent. The partners announced an analytical solution that will allow doctors to receive data real-time information about the health of patients in order to more quickly and effectively combat infectious diseases.

The SaaS solution BIOMÉRIEUX CLARION brings together the vast amount of medical data collected in U.S. hospitals and laboratories to provide critical information for public health. Among other things, the solution tracks the resistance of bacteria to drugs and with the help of SAS Viya quickly builds information panels for doctors, increasing the validity of their decisions. Ultimately, this will improve existing programs aimed at combating antibiotic resistance.

Doctors medical and scientific laboratory staff need to rely on real-time clinical data to make optimal decisions, says John Hurst, PhD pharmaceutical , BCIDP, senior director of the U.S. Division of Antibacterial Drugs bioMérieux. - The CLARION solution, which is based on SAS technologies, radically changes the surveillance of antibacterial drugs and allows the bacteria to quickly monitor the spectrum of antibiotic sensitivity automatically, constantly providing doctors with up-to-date information.

Antibiotic abuse, including inappropriate and excessive prescribing of these drugs by doctors, contributes to the development of bacteria and fungi and increases their resistance. This leads to 2.8 million cases of infectious diseases and more than 35,000 deaths in the United States alone. This problem worsened even more during the pandemic, as antibiotics began to be prescribed uncontrollably to patients with Covid-19, including preventively.

To monitor the effectiveness of antibiotics and their effect on a particular infection, they usually use a standard antibiotic chart, which is published once a year and contains only general information about pathogenic bacteria. Since this information refers to the past and may be outdated, there is an increased risk that the prescription physician will not be able to track current trends and prescribe an inappropriate antibiotic.

Despite the development of diagnostic technologies over the past 20 years, the very practice of using antibacterial drugs has not changed much, "says Steve Kearney, PhD, medical director of SAS. - CLARION uses the pros of SAS Viya's advanced data management, analytics, and data visualization to provide doctors with information that was previously unavailable to them.

The Centers for Disease Control and Prevention recommends that all U.S. hospitals develop antibacterial drug management programs to eliminate superbacteria (that is, antibiotic-resistant bacteria) and improve the quality of treatment. CLARION's advanced analytics solution provides critical laboratory and clinical data to various hospital divisions, and includes customizable warnings about antibiotic use. It personalizes antibacterial therapy decisions based on multiple factors and takes into account the unique characteristics of each particular patient.

CLARION significantly increases data availability. I now get information that used to be locally stored in laboratories, pharmacies, and electronic health records, "says Mike Broyles, PhD, director of pharmaceutical and laboratory services at St. Bernards Five Rivers (Arkansas, USA). - Now I can without additional requests, without spending time studying complex diagrams, get information in three clicks, while earlier it took three months.